Immune checkpoint inhibitors: a perspective of established and potential combination therapy
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2019-10, Vol.30, p.vi33 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | vi33 |
| container_title | Annals of oncology |
| container_volume | 30 |
| creator | Horinouchi, Hidehito |
| description | |
| doi_str_mv | 10.1093/annonc/mdz326.002 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz326_002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz326_002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c852-a7f8da58bb5135427a3b04357f5fe255117d633c0b65ab0f3da8a7441da0d24b3</originalsourceid><addsrcrecordid>eNot0LtOwzAUgGEPIFEKD8DmF0h7bMe5sKGKS6VKLB2RouObYkjsyDZI5ekBlenf_uEj5I7BhkEvthhCDHo7m2_Bmw0AvyAr6LmoWinqK3Kd8zsAND3vV-RtP8-fwVI9Wv2xRB8K9WH0ypeY8j1FutiUF6uL_7I0OmpzQTX5PFpDMRi6xGJD8ThRHWflAxYfAy2jTbicbsilwynb2_-uyfHp8bh7qQ6vz_vdw6HSneQVtq4zKDulJBOy5i0KBbWQrZPOcikZa00jhAbVSFTghMEO27pmBsHwWok1YeetTjHnZN2wJD9jOg0Mhj-R4SwynEWGXxHxA1JJWzM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Immune checkpoint inhibitors: a perspective of established and potential combination therapy</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Horinouchi, Hidehito</creator><creatorcontrib>Horinouchi, Hidehito</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz326.002</identifier><language>eng</language><ispartof>Annals of oncology, 2019-10, Vol.30, p.vi33</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Horinouchi, Hidehito</creatorcontrib><title>Immune checkpoint inhibitors: a perspective of established and potential combination therapy</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNot0LtOwzAUgGEPIFEKD8DmF0h7bMe5sKGKS6VKLB2RouObYkjsyDZI5ekBlenf_uEj5I7BhkEvthhCDHo7m2_Bmw0AvyAr6LmoWinqK3Kd8zsAND3vV-RtP8-fwVI9Wv2xRB8K9WH0ypeY8j1FutiUF6uL_7I0OmpzQTX5PFpDMRi6xGJD8ThRHWflAxYfAy2jTbicbsilwynb2_-uyfHp8bh7qQ6vz_vdw6HSneQVtq4zKDulJBOy5i0KBbWQrZPOcikZa00jhAbVSFTghMEO27pmBsHwWok1YeetTjHnZN2wJD9jOg0Mhj-R4SwynEWGXxHxA1JJWzM</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Horinouchi, Hidehito</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201910</creationdate><title>Immune checkpoint inhibitors: a perspective of established and potential combination therapy</title><author>Horinouchi, Hidehito</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c852-a7f8da58bb5135427a3b04357f5fe255117d633c0b65ab0f3da8a7441da0d24b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horinouchi, Hidehito</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horinouchi, Hidehito</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune checkpoint inhibitors: a perspective of established and potential combination therapy</atitle><jtitle>Annals of oncology</jtitle><date>2019-10</date><risdate>2019</risdate><volume>30</volume><spage>vi33</spage><pages>vi33-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz326.002</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2019-10, Vol.30, p.vi33 |
| issn | 0923-7534 |
| language | eng |
| recordid | cdi_crossref_primary_10_1093_annonc_mdz326_002 |
| source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| title | Immune checkpoint inhibitors: a perspective of established and potential combination therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T11%3A32%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune%20checkpoint%20inhibitors:%20a%20perspective%20of%20established%20and%20potential%20combination%20therapy&rft.jtitle=Annals%20of%20oncology&rft.au=Horinouchi,%20Hidehito&rft.date=2019-10&rft.volume=30&rft.spage=vi33&rft.pages=vi33-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz326.002&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz326_002%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |